Anaptysbio (ANAB) FCF Margin Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | 169,931.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,931.00 |
| Dec 31, 2025 | 34,677.00 |
| Sep 30, 2025 | 132,015.00 |
| Jun 30, 2025 | 180,020.00 |
| Mar 31, 2025 | 213,349.00 |
| Dec 31, 2024 | 223,785.00 |
| Sep 30, 2024 | -3,771.00 |
| Jun 30, 2024 | -23,829.00 |
| Mar 31, 2024 | -28,408.00 |
| Dec 31, 2023 | -44,666.00 |
| Mar 31, 2023 | -149,682.00 |
| Dec 31, 2022 | 31,408.00 |
| Jun 30, 2022 | -167,423.00 |
| Sep 30, 2021 | 27,444.00 |
| Dec 31, 2020 | 22,841.00 |
| Dec 31, 2019 | 2,680.00 |
| Jun 30, 2019 | -34,770.00 |